EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent 09.04.2025 / 15:07 CET/CEST The issuer is solely responsible ...

Deep funding cuts and widespread layoffs impact everything from local public health outreach to global disease surveillance, making us more vulnerable, experts warn.

In summary, the study shows exciting promise for a simple, plant-based solution to a complex global problem. By using natural ...

In today's interconnected world, infectious diseases pose an escalating threat, as demonstrated by the coronavirus pandemic ...

Low vaccination rates for influenza viruses and the lack of an HSV vaccine underscore the need for a new approach to reduce viral transmission. Researchers have now used a clinical-grade antiviral ...

The 24 pathogen families listed in the reference tool include microorganisms that cause Covid-19 and Nipah virus, among ...

Five years after COVID-19 reached pandemic status, public health experts reflect on what we learned—and how those lessons can ...

According to the World Health Organization data, Uganda's last Ebola outbreak observed from September 2022 to January 2023 resulted in 164 cases and 77 deaths. Open Modal × ...

Your doctor will probably give you an antiviral drug called ... regions. Ebola is deadlier, with a fatality rate of about 50%. In comparison, about 1% of people with Lassa virus will die.

the Africa Centres for Disease Control and Prevention (Africa CDC), have in recent weeks intensified sensitisation of communities in the Ebola virus disease-affected districts. Thanks to support ...

A day after getting exposed to the Ebola virus, ten monkeys then received an Obeldesivir pill daily for ten days, while three control monkeys received no treatment and died. The study found that ...

Researchers infected two types of monkeys, rhesus and cynomolgus macaques, with a high dose of the Ebola virus (Makona variant). One day later, ten monkeys were given a daily Obeldesivir pill for ten ...